HCP Marketing Blogs

09|02|21

On Speakers Programs and PhRMA’s Updated Ethics Code

Learn about the updates and how Intouch develops memorable and impactful speaker programs while staying within the guardrails.

04|06|21

Marketing to HCPs as We Emerge From the COVID-19 Pandemic

In the face of relentless trauma, how can pharma more effectively convey important information while also building, improving, and sustaining relationships with HCPs as they care for patients? An Intouch MD weighs in.

02|25|21

HCPs Need More From Digital Pharma: Research Shows Dissatisfaction, Offers Insights

When it comes to engaging HCPs online, the old ways aren’t cutting it. How is your brand helping them get the information — and the experience — they want, when they want it?

02|23|21

The Now and the Next: Advice for Pharma Marketers in the New Normal

No time to read our comprehensive whitepaper on thriving despite the challenges the pandemic has brought? John Kenny, Intouch’s strategic planning guru, has the key takeaways.

01|28|21

Concierge Medicine: The Good, the Bad, and the Ugly

How does concierge medicine affect patients, healthcare providers, and pharma? And what’s pharma’s role in this growing healthcare arena? Read on to find out.

10|19|20

HCP > MD: How Brands Can Help NPs and PAs Improve Healthcare

Brands can help patients and physicians by building and strengthening their relationships with NPs and PAs. Engaging them helps the entire care team perform at a higher level. Learn how here!

08|05|20

The Evolution of Retail Healthcare Models

Major national pharmacy chains have announced new options for patients who would like affordable, one-stop, comprehensive healthcare outside of the traditional care setting, as well as new opportunities for PCPs. Three Intouch market access experts offer considerations and opportunities for pharma marketers to navigate this growing retail healthcare delivery trend.

08|04|20

Intouch Innovation Expert Weighs in on the New World of Virtual Health

To better understand the impact of the new virtual health landscape, the DHC Group recently conducted research including thought leader roundtables, physician surveys via the SERMO network, and interviews with pharma marketers, including Intouch director of innovation, Brendon Thomas.

03|16|20

Coronavirus (COVID-19) and Its Effect on Pharmaceutical Marketing and Sales

Due to COVID-19 and its impact on people and health systems, pharmaceutical marketers will be seeking new ways to engage with their customers. This POV will address those challenges and also elaborate on the opportunities pharma marketers have to help their healthcare customers, as well as patients, and build relationships with both audiences for the future, once this health crisis has passed.

03|12|20

Telehealth & Pharma – Finding a Niche in This Rapidly Growing Field

With the rapid spread of Coronavirus disease 2019 (COVID-19) throughout the United States, many pharmaceutical companies are being forced to prepare for a scenario in which their sales representatives cannot visit healthcare providers (HCPs) and patients are limited in their ability to visit healthcare facilities. This infographic looks at how telehealth services can play an […]

Load More Posts